Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors
PARIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liqui...
Stay updated with breaking news from Trex Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liqui...
'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'
Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following changes to its Executive Committee: Houman Ashrafian is appointed as Head of Research &...
Female sex, hyperlipidemia, Medicaid insurance, earlier year of biologic initiation, shorter duration of psoriasis, and prior nonbiologic systemic therapy use were associated with multiple biologic failure.
Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma